Phase Ib Study of Unesbulin (PTC596) Plus Dacarbazine for the Treatment of Locally Recurrent, Unresectable or Metastatic, Relapsed or Refractory Leiomyosarcoma.

Details

Language :

English

ISSN :

0732183X

Volume :

42

Issue :

20

Database :

Supplemental Index

Journal :

Journal of Clinical Oncology

Publication Type :

Academic Journal

Accession number :

178228256

Full Text :

https://doi.org/10.1200/JCO.23.01684